Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-14 Sale |
2023-12-18 6:29 pm |
Rain Oncology Inc. | RAIN | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner |
173,973 | $1.2037 | $209,413 | 3,850,513 (Indirect) |
View |
| 2023-10-11 Purchase |
2023-10-13 4:57 pm |
Rain Oncology Inc. | RAIN | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner |
284,145 | $0.982 | $279,030 | 4,024,486 (Indirect) |
View |
| 2023-05-30 Purchase |
2023-06-01 6:46 pm |
Rain Oncology Inc. | RAIN | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner |
1,088,273 | $1.0648 | $1,158,764 | 3,740,341 (Indirect) |
View |
| 2023-05-22 Sale |
2023-05-24 8:05 pm |
Rain Oncology Inc. | RAIN | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH Davis Aaron I. See remarks. |
995,000 | $1.25 | $1,243,750 | 1,152,212 (Direct) |
View |
| 2022-11-21 Purchase |
2022-11-23 5:45 pm |
Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director |
122,000 | $8.0966 | $987,790 | 1,005,207 (Direct) |
View |
| 2022-11-08 Purchase |
2022-11-14 4:17 pm |
Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director |
42,881 | $5.83 | $249,996 | 883,207 (Direct) |
View |
| 2022-11-08 Purchase |
2022-11-10 6:31 pm |
Rain Therapeutics Inc. | RAIN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses 10% Owner |
1,710,358 | $5.83 | $9,971,387 | 3,649,733 (Indirect Direct) |
View |
| 2022-11-04 Purchase |
2022-11-08 4:30 pm |
Rain Therapeutics Inc. | RAIN | Davis Aaron I. Director |
972,212 | $5.83 | $5,667,996 | 5,649,427 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-26 Equity Swap |
2024-02-02 4:00 pm |
N/A N/A |
Rain Oncology Inc. | RAIN | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner |
3,850,513 | $0 | 0 (Indirect) |
View |
| 2024-01-25 Equity Swap |
2024-01-29 8:40 pm |
N/A N/A |
Rain Oncology Inc. | RAIN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks; Former 10% Owner |
8,576,803 | $0 | 0 (Direct) |
View |
| 2024-01-26 Equity Swap |
2024-01-26 4:49 pm |
N/A N/A |
Rain Oncology Inc. | RAIN | Radovich Peter Director |
8,796 | $0 | 0 (Direct) |
View |
| 2024-01-26 Equity Swap |
2024-01-26 4:41 pm |
N/A N/A |
Rain Oncology Inc. | RAIN | Davis Aaron I. Director |
79,726 | $0 | 0 (Direct) |
View |
| 2024-01-26 Equity Swap |
2024-01-26 4:39 pm |
N/A N/A |
Rain Oncology Inc. | RAIN | BERGER FRANKLIN M Director |
1,005,207 | $0 | 0 (Direct) |
View |
| 2024-01-26 Equity Swap |
2024-01-26 4:36 pm |
N/A N/A |
Rain Oncology Inc. | RAIN | Doebele Robert See Remarks |
476,827 | $0 | 0 (Direct) |
View |
| 2024-01-26 Equity Swap |
2024-01-26 4:34 pm |
N/A N/A |
Rain Oncology Inc. | RAIN | Vellanki Avanish Chairman and CEO |
2,550,910 | $0 | 0 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:17 pm |
N/A 2033-08-09 |
Rain Oncology Inc. | RAIN | Vellanki Avanish Chairman and CEO |
399,750 | $0 | 399,750 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:16 pm |
N/A 2033-08-09 |
Rain Oncology Inc. | RAIN | Doebele Robert See Remarks |
149,100 | $0 | 149,100 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:14 pm |
N/A 2033-08-09 |
Rain Oncology Inc. | RAIN | BERGER FRANKLIN M Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:12 pm |
N/A 2033-08-09 |
Rain Oncology Inc. | RAIN | Radovich Peter Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:11 pm |
N/A 2033-08-09 |
Rain Oncology Inc. | RAIN | Nguyen Tran Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:09 pm |
N/A 2033-08-09 |
Rain Oncology Inc. | RAIN | Wolff Stefani Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:07 pm |
N/A 2033-08-09 |
Rain Oncology Inc. | RAIN | Hrustanovic Gorjan Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:05 pm |
N/A 2033-08-09 |
Rain Oncology Inc. | RAIN | Davis Aaron I. Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:04 pm |
N/A 2033-08-09 |
Rain Oncology Inc. | RAIN | Atkisson Erik General Counsel and CCO |
60,251 | $0 | 60,251 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:01 pm |
N/A 2033-08-09 |
Rain Oncology Inc. | RAIN | Bruce Josephine Principal Fin. & Acc. Officer |
10,800 | $0 | 10,800 (Direct) |
View |
Ownership |
2023-06-09 4:05 pm |
N/A N/A |
Rain Oncology Inc. | RAIN | Bruce Josephine Principal Fin. & Acc. Officer |
0 | $0 | 22,386 (Direct) |
View |
Ownership |
2023-06-01 6:44 pm |
N/A N/A |
Rain Oncology Inc. | RAIN | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner |
0 | $0 | 2,652,068 (Indirect) |
View |
| 2023-03-02 Option Award |
2023-03-03 5:07 pm |
N/A 2033-03-02 |
Rain Oncology Inc. | RAIN | Atkisson Erik General Counsel and CCO |
120,000 | $0 | 120,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 6:23 pm |
N/A 2033-02-15 |
Rain Oncology Inc. | RAIN | Cabatuan Nelson VP of Finance & Admin |
65,325 | $0 | 65,325 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 6:21 pm |
N/A 2033-02-15 |
Rain Oncology Inc. | RAIN | BRYCE RICHARD PAUL Chief Medical Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 6:18 pm |
N/A 2033-02-15 |
Rain Oncology Inc. | RAIN | Doebele Robert See Remarks |
123,325 | $0 | 123,325 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 6:15 pm |
N/A 2033-02-15 |
Rain Oncology Inc. | RAIN | Vellanki Avanish Chairman and CEO |
318,600 | $0 | 318,600 (Direct) |
View |
| 2022-06-01 Option Award |
2022-08-19 5:43 pm |
N/A 2032-06-01 |
Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-08-19 5:40 pm |
N/A 2032-06-01 |
Rain Therapeutics Inc. | RAIN | Davis Aaron I. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-08-19 5:38 pm |
N/A 2032-06-01 |
Rain Therapeutics Inc. | RAIN | Nguyen Tran Director |
20,000 | $0 | 20,000 (Direct) |
View |